1 / 14

CVD/HIV Integration Initiative: Kenya Case Study 16 July 2010

CVD/HIV Integration Initiative: Kenya Case Study 16 July 2010. Dr. Frank Mwangemi , Acting Deputy Director, USAID APHIA II Coast, FHI/Kenya Dr. Peter Lamptey , President, Public Health Programs, FHI. Rationale for integration. CVD complications in HIV patients

gurit
Download Presentation

CVD/HIV Integration Initiative: Kenya Case Study 16 July 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CVD/HIV Integration Initiative:Kenya Case Study16 July 2010 Dr. Frank Mwangemi, Acting Deputy Director, USAID APHIA II Coast, FHI/Kenya Dr. Peter Lamptey, President, Public Health Programs, FHI

  2. Rationale for integration • CVD complications in HIV patients • Burden of CVD and HIV among developing countries; In Kenya: • HIV prevalence is 7.1%, with 1.5 Million PLWHA, and 390,000 on HAART • NCD contributes to 50% morbidity and 32% mortality (Kenya MOH, 2007) • Opportunity to combine lessons learned in CVD &HIV • Improve efficiency of health care delivery

  3. Objectives of CVD/HIV Integration Pilot • Assess CVD risk factors among: • HIV Counseling & Testing (CT) clients • HIV+ patients in care • HIV+ patients on ART • Provide behavioral and biomedical interventions (on site and/or through referral) • Document and disseminate lessons learned

  4. Start –up activities • Secure funding: FHI seed funding, USAID funding for APHIA II • Involve key MOH officials: NASCOP, provincial and district health officials • Establish partnership with KCS and KNHF • Select, assess & equip the selected facilities • Develop training modules, adopt job aids, develop record forms • Train health care workers & counsellors

  5. Implementation of integrated HIV/CVD services • Launched in September 2009 in 5 sites – Coast and Rift Valley provinces • CVD risk assessment • Behavioural factors: physical activity, diet, tobacco use, etc. • Biological factors • Therapeutic factors • Quarterly monitoring and support supervision by joint MOH/KCS/FHI staff

  6. Benefits of integrating CVD into HIV services • Strengthens the Health System! • Policy: KNASP III • Service Delivery • Health workforce • Health management information system • Supply chain management • Laboratory • Financing • Technical and program management leadership

  7. Demographic characteristics of clients

  8. Risk of high blood pressure according to HIV status (among CT clients) P-value 0.003

  9. Risk of high blood pressure according to duration on ART and HIV status P-value 0.003

  10. Risk of high blood pressure according to ARV regimen P-value 0.000

  11. Risk of elevated blood sugar according to ARV regimen P-value 0.058

  12. Risk of high cholesterol according to ARV regimen P-value 0.917

  13. Conclusions Preliminary assessment suggests: • HIV/CVD integration is feasible • Integration can identify undetected CVD risk factors • Integration can support the prevention and management of CVD risk factors • Routine monitoring of blood pressure should be part of AIDS care and treatment • Further analysis of data to be done • Further operations research and assessment of CVD risks in HIV patients in LMIC is required

  14. Acknowledgements Ministries of Medical Services and Public Health and Sanitation PEPFAR/USAID NASCOP Kenya Cardiac Society (KCS) Health providers at the 5 pilot sites

More Related